Daily Dose: "Eat, Sleep, Console" Approach for Neonatal Opioid Withdrawal
Your daily dose of clinical news you may have missed.
FDA Approves World's First Vaccine Against Respiratory Syncytial Virus
The novel vaccine, from biopharma company GSK, is approved to prevent RSV-associated lower respiratory tract disease in adults aged ≥60 years.
ACP Announces Intensified Advocacy for Equitable Care of Obesity
The American College of Physicians announced an initiative that renews and expands its focus on equitable access to obesity care, including new resources for physicians.
Use of KidneyIntelX in Patients With DKD
Experts in diabetic nephropathy present a study of the use of the KidneyIntelX test in patients with DKD.
Role of DKD Progression Screening Tools
Experts review the role of the urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) in current DKD progression screening practices.
ACP 2023 Guideline on Pharmacologic Treatment of Osteoporosis: A Guideline Topline
The updated American College of Physicians osteoporosis treatment guideline is summarized in this topline review for primary care clinicians.
New Research May Help Clinicians Identify Children at a Higher Risk for Self-harm Events
In a study of over 1000 children and adolescents, authors identified 4 distinct profiles of psychiatric comorbidity with differing risk for a self-harm event.
Daily Dose: Brain Function Changes in Persons with Long COVID
"Eat, Sleep, Console" Reduces Hospital Stay, Medication Use in Opioid-exposed Neonates
Infants with neonatal opioid withdrawal syndrome cared for using a novel functional approach were discharged nearly 7 days sooner than those treated with usual care.
Poor Access to Transportation Often Leads to Missed Medical Care
One in 5 US adults without access to transportation skipped medical care last year, with racial/ethnic minorities at greatest risk, study finds.
Remote Intervention Increases 3 Cancer Screenings Among Women in Rural US
A combination of outreach measures tailored to the needs of rural Midwest women increased recommended screenings by as much as 6-fold.
Psychological Interventions for Depression Associated with Reduced CVD Risk in New Study
Researchers found that reliable improvement of depressive symptoms after psychological therapy was associated with a 12% decrease in CVD risk at any given time.
Daily Dose: Tirzepatide for Adults with Overweight, Obesity
Long COVID Diagnosis & Treatment: Many US Physicians Have Doubts
The US health care provider community continues to do its collective best to cope with the protean condition that is long COVID, according to recent poll findings.
Persistent Changes in Brain Function Observed in Persons with Long COVID
Persons with long COVID showed compensatory neural activity in certain brain areas while performing memory tasks as long as 6 months after infection resolved.
Daily Dose: Mislabeled Melatonin Gummy Products
FDA Approves First Oral Microbiota Biotherapeutic for Recurrent C. difficile Infection
Vowst is the first and only FDA-approved orally administered microbiota-based therapeutic for the prevention of recurrent C. diff infection in adults.
Friday's 5 Quotes for Primary Care 4-28-2023
"Disconnect" on anticoagulation between MDs and patients; NASH resolves after bariatric surgery; antiobesity medications are not weight-loss drugs; plus 2 more updates of note.
Tirzepatide Delivers Weight Loss of 15.7% in Adults with Overweight, Obesity
Dubbed the "twincretin," the GLP-1/GIP RA met weight and HgbA1c reduction endpoints, with nearly half of tirzepatide-treated patients achieving weight loss of at least 15%.
Professional Societies, Concerned Clinicians Create Guides to Navigate Burnout
The AHRQ, Mayo Clinic, AMA, and National Academy of Medicine each recommend actions steps for all organizational levels to help build more supportive environments.
